Frank Rimerman Advisors LLC Purchases 2,478 Shares of Becton, Dickinson and Company (NYSE:BDX)

Frank Rimerman Advisors LLC lifted its position in Becton, Dickinson and Company (NYSE:BDX) by 6,043.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,519 shares of the medical instruments supplier’s stock after acquiring an additional 2,478 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Becton, Dickinson and Company were worth $589,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Livelsberger Financial Advisory purchased a new position in shares of Becton, Dickinson and Company during the fourth quarter valued at approximately $27,000. OLD Point Trust & Financial Services N A purchased a new position in Becton, Dickinson and Company during the 4th quarter valued at $29,000. Scarborough Advisors LLC purchased a new stake in Becton, Dickinson and Company in the fourth quarter worth $32,000. Rise Advisors LLC bought a new stake in shares of Becton, Dickinson and Company during the first quarter worth $38,000. Finally, ICA Group Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company during the fourth quarter valued at $42,000. 86.97% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

BDX has been the subject of a number of research analyst reports. The Goldman Sachs Group began coverage on shares of Becton, Dickinson and Company in a report on Thursday, May 30th. They set a “buy” rating and a $274.00 price objective for the company. Raymond James dropped their price objective on Becton, Dickinson and Company from $275.00 to $270.00 and set an “outperform” rating on the stock in a research note on Friday, August 2nd. Stifel Nicolaus lifted their target price on Becton, Dickinson and Company from $270.00 to $280.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Evercore ISI dropped their price target on Becton, Dickinson and Company from $290.00 to $285.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 2nd. Finally, Citigroup decreased their price objective on Becton, Dickinson and Company from $260.00 to $255.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $279.50.

Becton, Dickinson and Company Stock Up 0.5 %

Shares of Becton, Dickinson and Company stock opened at $234.70 on Tuesday. The company has a quick ratio of 1.36, a current ratio of 1.85 and a debt-to-equity ratio of 0.70. The company has a market cap of $67.83 billion, a P/E ratio of 51.70, a PEG ratio of 1.91 and a beta of 0.42. The firm’s 50 day moving average price is $235.68 and its 200-day moving average price is $235.52. Becton, Dickinson and Company has a 52-week low of $218.75 and a 52-week high of $269.52.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $3.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.31 by $0.19. The business had revenue of $4.99 billion for the quarter, compared to the consensus estimate of $5.08 billion. Becton, Dickinson and Company had a return on equity of 14.49% and a net margin of 7.13%. The business’s quarterly revenue was up 2.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.96 earnings per share. On average, sell-side analysts predict that Becton, Dickinson and Company will post 13.1 EPS for the current fiscal year.

Becton, Dickinson and Company Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 9th will be paid a dividend of $0.95 per share. The ex-dividend date is Monday, September 9th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.62%. Becton, Dickinson and Company’s payout ratio is 83.70%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.